Results 191 to 200 of about 50,152 (259)

Real-world effectiveness of medication-assisted treatment and psychotherapy for opioid use disorder: a national multi-health care organization analysis. [PDF]

Front Psychiatry
Graziane NM.
europepmc   +1 more source

Patient perspectives on buprenorphine/naloxone for chronic noncancer pain: A qualitative interview study. [PDF]

Can J Pain
Halpape K, Jorgenson D, Rogers M.
europepmc   +1 more source

Identification of Subtype-Selective Binding Sites in the Opioid Receptor Family. [PDF]

J Chem Inf Model
S Gomes AA, Guillot B, Jelsch C, Giraldo J.   +3 more
europepmc   +1 more source

Social Determinants of Health and 1-Year Buprenorphine Initiation Among Justice-Involved Veterans.

JAMA Netw Open
Sultana S, Ouyang F, Qian J, Zhang Y, Mitra A, Pradhan R, Moradi Y, Pogoda TK, Reisman JI, Yu H.   +9 more
europepmc   +1 more source

State Prior Authorization Prohibitions and Buprenorphine Retention Among Privately Insured Patients.

JAMA Health Forum
Hu JC, Kapadia SN, Zhang H, Jalali A, Underhill K, Andrews CM, Bao Y.   +6 more
europepmc   +1 more source

Error in Conclusions.

JAMA Intern Med
europepmc   +1 more source

Medication and Acute Care Use in Young Adults With Opioid Use Subject to Medicaid Prescription Caps.

JAMA Health Forum
Santostefano CM, Hughto JMW, Hughes LD, Shireman TI, Andrews C, Rosales R, Donohue JM, Peterson L, Dow PM.   +8 more
europepmc   +1 more source

Error in Figure.

JAMA
europepmc   +1 more source